panitumumab FDA approval date

The FDA approved panitumumab on 27 Sep 2006.

FDA approval date
27 Sep 2006

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal CancerNCT07659795VSTMPhase 2Recruiting2027-06Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2006-09-27DaypanitumumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125147", "applicant_as_listed_by_fda": "AMGEN", "brand_names": ["VECTIBIX"], "active_ingredients": ["PANITUMUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060927", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026